Dyck Peter J, Dyck P James B, Klein Christopher J, Weigand Stephen D
Peripheral Neuropathy Research Laboratory, Mayo Clinic, Rochester, MN 55905, USA.
Muscle Nerve. 2007 Oct;36(4):536-41. doi: 10.1002/mus.20846.
In spite of extensive studies it is unclear whether impaired fasting glucose (IFG) or impaired glucose tolerance (IGT), i.e., impaired glucose metabolism (IGM), causes diabetic sensorimotor polyneuropathy (DSPN) or chronic idiopathic axonal polyneuropathy (CIAP); the results and conclusions vary considerably in different studies. Some studies suggest that IGM is a common and important cause of CIAP, whereas others do not. On reviewing these data, we judge that a considerable degree of this disparity may relate to differences in selection of patients, choice of controls, assessment of chronic glycemic exposure and of diabetic complications, and statistical power. Here we review previous studies, list the reasons that the issue needs further study, and outline a study now in progress to address the question more definitively.
尽管已有大量研究,但目前尚不清楚空腹血糖受损(IFG)或糖耐量受损(IGT),即糖代谢受损(IGM),是否会导致糖尿病性感觉运动性多发性神经病变(DSPN)或慢性特发性轴索性多发性神经病变(CIAP);不同研究的结果和结论差异很大。一些研究表明IGM是CIAP常见且重要的病因,而另一些研究则不然。在审视这些数据时,我们判断这种差异在很大程度上可能与患者选择、对照选择、慢性血糖暴露及糖尿病并发症的评估以及统计效能的差异有关。在此,我们回顾既往研究,列出该问题需要进一步研究的原因,并概述一项正在进行的研究,以更明确地解决该问题。